NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/16/2025
Back to search
Official data from USPTO
AZAD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079215450Class
35, 39, 40, 42, 44, 45
Filing
79215450
Registration
5450649
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
05/17/2025
Trademark type
Combined
Nice classes
35, 39, 40, 42, 44, 45
Filing date
06/01/2017
Registration date
04/24/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/06/2024
Last transaction
05/17/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
Schaffhausen, CH
Examiner
AVENT, TEAGUE
Current location
Historical data usage
Mark description
The mark consists of the stylized wording "AZAD". The first letter "A" is stylized such that its bottom creates an image of a stylized leaf in negative space. The second letter "A" is stylized such that its bottom creates an image of a stylized Greek cross in negative space.
Holders and representatives
Holders
AZAD Pharma AG
AZAD Pharmaceutical Ingredients AG
Representatives
Stacey Halpern Knobbe, Martens, Olson & Bear, LLP
Technical classification
Nice Classes
Class 35Class 39Class 40Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Commercial consultancy and assistance before authorizing authorities
Class 39
Transport of pharmaceutical products; Warehousing servicespackagingstorage and distribution of pharmaceutical products
Class 40
Custom synthesis and manufacturing of active pharmaceutical ingredientsintermediates thereof and finished dosage formsespecially for pharmaceutical use
Class 42
Scientific and technological servicesresearch and design in the field of pharmaceuticals and active pharmaceutical ingredients; scientific and technological consultancy in the field of pharmaceuticalsrendering technical assistance to authorizing authorities to obtain related market authorizationindustrial research and analysis in the field of pharmaceuticals and active pharmaceutical ingredients; biological research services; chemical analysis; chemical researchchemistry servicessynthesis and manufacturing of active pharmaceutical ingredientsintermediates thereof and finished dosage formsfor pharmaceutical research use; analysis and quality control for others of pharmaceuticals and their manufacturing process; research and development of new pharmaceutical products for others
Class 44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; pharmacy advicemedical and pharmaceutical consultancy and assistance before authorizing authorities
Class 45
Legal services and representationintellectual property consultancy; intellectual property licensing
Publications
History of USPTO decisions and trademark events.
38 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/06/2024
71AG
REGISTERED-SEC.71 ACCEPTED
09/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/03/2024
ES71
TEAS SECTION 71 RECEIVED
11/29/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/24/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/19/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/31/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/06/2018
FIMP
FINAL DISPOSITION PROCESSED
08/06/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/24/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/24/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2018
PUBO
PUBLISHED FOR OPPOSITION
02/06/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/17/2018
RFNT
REFUSAL PROCESSED BY IB
01/06/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/15/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
12/15/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/15/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
12/15/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/15/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/27/2017
GNRT
NON-FINAL ACTION E-MAILED
11/27/2017
CNRT
NON-FINAL ACTION WRITTEN
11/27/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2017
ALIE
ASSIGNED TO LIE
11/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/23/2017
RFNT
REFUSAL PROCESSED BY IB
09/30/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/14/2017
RFRR
REFUSAL PROCESSED BY MPU
09/14/2017
MAFR
APPLICATION FILING RECEIPT MAILED
09/12/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/11/2017
CNRT
NON-FINAL ACTION WRITTEN
09/10/2017
DOCK
ASSIGNED TO EXAMINER
09/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/06/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/31/2017
Continuous trademark protection
Get notified about every new filing that threatens AZAD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.